King's College spins out Centron Diagnostics

King's College London has spun out Centron Diagnostics, a start-up that will use new technology to measure central blood pressure. The device, which is worn on the arm, will measure both traditional arm blood pressure and central blood pressure, which the company says can be difficult to monitor. Centron Diagnostics' device requires no special training for healthcare professionals and costs less than currently-available central blood pressure monitors. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.